Both recombinant <i>Bacillus subtilis</i> Expressing PCV2d Cap protein and PCV2d-VLPs can stimulate strong protective immune responses in mice.

Abstract

Porcine circovirus type 2 (PCV2) is one of the most serious pathogens in pig herds worldwide. The Capsid protein (Cap), a structural protein of PCV2, is involved in the host's immune response; it induces neutralizing-antibody production and has good immunogenicity. The main PCV2 subtype currently prevalent in the Chinese pig herd is PCV2d. In this study, We constructed a recombinant <i>Bacillus subtilis</i> (<i>B. subtilis</i>) capable of secreting Cap protein, named pHT43-Cap/<i>B. subtilis</i>; we concentrated the supernatant of the recombinant bacteria and observed virus-like particles (VLPs) of PCV2d formed by Cap protein under transmission electron microscopy, named PCV2d-VLPs. The immunocompetence of the pHT43-Cap/<i>B. subtilis</i> and PCV2d-VLPs were then assessed by oral administration and by intramuscular injection into mice, respectively. The results showed that the levels of PCV2d-Cap protein-specific IgG in the serum and of PCV2d-Cap protein-specific sIgA in the small intestinal fluid of pHT43-Cap/<i>B. subtilis</i> immunized mice were elevated compared to the control group, both of them highly significant (<i>p</i> < 0.01), and the corresponding serum-specific IgG antibodies were effective in neutralizing PCV2d virulence. The virus load in the liver of the immunized mice was significantly lower than that in the control group (<i>p</i> < 0.01), as was the virus load in the spleen and lungs of the immunized mice (<i>p</i> < 0.05). In addition, the serum levels of PCV2d-Cap-specific IgG in mice immunized with PCV2d-VLPs by intramuscular injection were significantly elevated compared to the control group (<i>p</i> < 0.05), and the viral load in all tissues was significantly lower in immunized mice (<i>p</i> < 0.05). In conclusion, the recombinant bacterium pHT43-Cap/<i>B. subtilis</i> can induce effective mucosal and humoral immunity in mice, PCV2d-VLPs can induce humoral immunity in mice, and both vaccines have good immunogenicity; these results provide a theoretical and material basis for the development of a new vaccine against PCV2d.